RSS FEEDS BLOG
Sanofi [NASDAQ: SNY] disclosed that it has decided to purchase Origimm Biotechnology GmbH which is an Austrian privately-owned biotechnology company focusing on the invention of virulent skin microbiome components and antigens from bacteria causing skin…
Lithium Americas Corp. [NYSE: LAC] disclosed that it has inked an agreement to purchase all of the outstanding shares of Millennial. LAC will buy Millennial by way of a plan of arrangement for C$4.70 per…
KKR & Co. Inc. [NYSE: KKR] disclosed that it has inked an agreement to purchase Japanese chemical storage tank operator Central Tank Terminal (CTT) from an associate of Macquarie Infrastructure and Real Assets (MIRA). CTT…
Theratechnologies Inc. [NASDAQ: THTX] revealed that it has inked a reimbursement pact with the Italian Medicines Agency, AIFA. The pact is for the reimbursement of Trogarzo for qualified people aged 18 and older living with…
Incyte Corporation [NASDAQ: INCY] disclosed that it has inked a supply distribution pact with Specialised Therapeutics Asia Pte Ltd. Both the companies have joined forces to unveil and deliver two new medicines for their Haematology…
Stellantis N.V. [NYSE: STLA] disclosed that it has joined hands with LG Energy Solution. Both the firm has inked a Memorandum of Understanding (MoU) to establish a joint venture. The firms will manufacture battery cells…
KKR & Co. Inc. [NYSE: KKR] disclosed that it has inked an acquisition agreement with Quadrant Private Equity, Five V Capital, Rodney Kagan, and other shareholders of Probe CX. As per the agreement, KKR has…
Huntsman Corporation [NYSE: HUN] has disclosed that it has joined forces with KPX Chemical to launch a joint venture (JV) in Korea. The joint venture will be named KPX HUNTSMAN POLYURETHANES AUTOMOTIVE CO., LTD. (KHPUA).…
Gores Guggenheim, Inc. [NASDAQ: GGPIU] has inked a merger agreement with Polestar Performance AB and its affiliates which is the global electric performance car firm. After the finalization of the proposed business combination, the merged…
Novartis AG [NYSE: NVS] disclosed that it has acquired Arctos Medical. This purchase decision will add a pre-clinical optogenetics-based AAV gene therapy program and Arctos’ proprietary technology to its ophthalmology portfolio. Optogenetics is a promising…
Copyright 2021 RSSFeeds.CloudSite.Builders | Design & develop by AmpleThemes